by admin_prosemble | 18th April 2025 | News
18 April 2025 – London, UK – Prosemble is honoured to have been selected by UKAI – the leading trade association representing UK AI businesses – to present its innovative protein nanoparticle and AI-driven technologies at the prestigious Healthcare and AI Showcase and...
by admin_prosemble | 17th April 2025 | News
17 April 2025 – London, UK – Prosemble is proud to announce its selection for the Cancer Tech Accelerator, a prestigious programme designed to support groundbreaking technologies with the potential to transform the early detection, diagnosis, monitoring, or treatment...
by admin_prosemble | 15th April 2025 | Articles
New bacterial protein could prove key to develop new cancer treatments https://www.europeanscientist.com/en/public-health/new-bacterial-protein-could-prove-key-to-develop-new-cancer-treatments/
by admin_prosemble | 20th March 2025 | Articles
Researchers Identify BeeR, a Novel Protein That May Enhance Drug Delivery in Cancer Care https://www.pharmacytimes.com/view/researchers-identify-beer-a-novel-protein-that-may-enhance-drug-delivery-in-cancer-care
by admin_prosemble | 20th March 2025 | Articles
BioTechniques: Could BeeR help design targeted cancer therapeutics? https://www.biotechniques.com/proteomics/could-beer-help-design-targeted-anticancer-drug-delivery-systems/
